Share Your Comments

Name*
Email*
ARN No/Firm Name*
City*
Comments*
Verification Code*
bGxhv9
Type the characters in the picture.
We trust that you will avoid using harsh language and will refrain from making unsubstantiated allegations against individuals and firms. Your constructive feedback and opinions are very valuable to all of us in the industry.

Liked this article?
Rate it on WF Like-o-meter!

Name*
Email*
(Name and Email ID will not be displayed once you click Submit)
Your rating : Click the appropriate pointer from the 5 below
(Low signifies didn't like and High signifies liked a lot)
WF Like-o-Meter

Check out the WF Like-o-meter score for
this article
0
Comments Posted
Name : Raajeev ChawlaCity : Varanasi
ARN NO : ARN-28987Date : 12 Apr 2016
Comments :
Mr. Dinesh, with all due respect, just take a ride with a small town distributor and sell the simplest product.
Name : Vipul DalalCity : Mumbai
ARN NO : ARN 89330Date : 11 Apr 2016
Comments :
Dear Mr Khara 1) I dont think pharma products & financial products distribution comparison is apple to apple simply because no two clients financial objectives are the same whereas doctors prescribe the same medication 2) How do the suggested changes increase MF penetration in our country? 3) Why are we blindly aping the west? Is Indias MF literacy as high as the US? 4) What has been the experience of even far more developed countries like Canada? 5) Ours is a 2.5% cost industry, and when everything is within this limit, why highlight only what distributors are earning?
Name : Dhiraj MittalCity : Delhi
ARN NO : prime capital servicDate : 11 Apr 2016
Comments :
I don’t agree that MFs can be segregated into OTC and prescription products. The key to mutual fund investing isn’t just buying, its more of staying put through volatility (even the basic liquid fund aren’t immune), periodical review & rebalancing and timely exit. Also, mutual fund means simple products, this is what the all industry participants/regulator wants and the products are getting simpler over time, so where is the scope for complex products in this industry. To increase the reach to unexplored, uncharted territories, one needs to know the ground reality, I suppose you/your team/the regulator spending a day every month in a distributors office would be of great help.
Name : V V AnandCity : Mumbai
ARN NO : 84193Date : 11 Apr 2016
Comments :
Mr. Khara is to be complimented for bringing some fresh views onto a topic that is already a much-flogged horse. However , the difference between pharma and financial products will make prescription the norm so that even commodities become specialised commoditties requiring approval. All human bodies are within a narrow range of weights and all are invariably at the same normal temperature.Even in weight, there is a difference between adults and children, with consequential changes in pharma dosage. However, "financial Body weights" vary enormously , as we all rue, and an advisor must first decide on asset allocation . Allocation to equity will vary as will debt , depending on the total wealth. Even Bank TDR is not really a pure commodity, since there is the risk of cxonservatism, which can disable even the smallman in the context of inflation. I hope AMC heads like Sri Khara could see their way to supprting search for universalisation of Advice.
Submit Your Comments
Name
ARN No/Co Name
Comments
Verification Code
* Email *
* City *
*
*
bGxhv9
Type the characters in the picture.
We trust that you will avoid using harsh language and will refrain from making unsubstantiated allegations against individuals and firms. Your constructive feedback and opinions are very valuable to all of us in the industry.
 
Comments Posted
Name : Raajeev ChawlaCity : Varanasi
ARN NO : ARN-28987Date : 12 Apr 2016
Comments :
Mr. Dinesh, with all due respect, just take a ride with a small town distributor and sell the simplest product.
Name : Vipul DalalCity : Mumbai
ARN NO : ARN 89330Date : 11 Apr 2016
Comments :
Dear Mr Khara 1) I dont think pharma products & financial products distribution comparison is apple to apple simply because no two clients financial objectives are the same whereas doctors prescribe the same medication 2) How do the suggested changes increase MF penetration in our country? 3) Why are we blindly aping the west? Is Indias MF literacy as high as the US? 4) What has been the experience of even far more developed countries like Canada? 5) Ours is a 2.5% cost industry, and when everything is within this limit, why highlight only what distributors are earning?
Name : Dhiraj MittalCity : Delhi
ARN NO : prime capital servicDate : 11 Apr 2016
Comments :
I don’t agree that MFs can be segregated into OTC and prescription products. The key to mutual fund investing isn’t just buying, its more of staying put through volatility (even the basic liquid fund aren’t immune), periodical review & rebalancing and timely exit. Also, mutual fund means simple products, this is what the all industry participants/regulator wants and the products are getting simpler over time, so where is the scope for complex products in this industry. To increase the reach to unexplored, uncharted territories, one needs to know the ground reality, I suppose you/your team/the regulator spending a day every month in a distributors office would be of great help.
Name : V V AnandCity : Mumbai
ARN NO : 84193Date : 11 Apr 2016
Comments :
Mr. Khara is to be complimented for bringing some fresh views onto a topic that is already a much-flogged horse. However , the difference between pharma and financial products will make prescription the norm so that even commodities become specialised commoditties requiring approval. All human bodies are within a narrow range of weights and all are invariably at the same normal temperature.Even in weight, there is a difference between adults and children, with consequential changes in pharma dosage. However, "financial Body weights" vary enormously , as we all rue, and an advisor must first decide on asset allocation . Allocation to equity will vary as will debt , depending on the total wealth. Even Bank TDR is not really a pure commodity, since there is the risk of cxonservatism, which can disable even the smallman in the context of inflation. I hope AMC heads like Sri Khara could see their way to supprting search for universalisation of Advice.